Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Pharmaceutical Science Advances
|
January 19, 2026
Microdynamic flowability for early API characterisation: A case study on Palbociclib
David Blanco, Nicolas Pätzmann, Pablo García-Triñanes
AAPS Pharmscitech
|
November 14, 2025
Exploring co-milling of poorly water-soluble drugs with swellable polymers to enhance the dissolution rate
Nicolas Pätzmann, Josef Beránek, Brendan T Griffin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 2, 2024
Predictive computational models for assessing the impact of co-milling on drug dissolution
Nicolas Pätzmann, Patrick J O'Dwyer, Josef Beránek, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 26, 2025
Co-milling of glass forming ability class III drugs: Comparing the impact of low and high glass transition temperatures
Nicolas Pätzmann, Josef Beránek, Brendan T Griffin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Pharmaceutical Science Advances
|
January 19, 2026
Microdynamic flowability for early API characterisation: A case study on Palbociclib
David Blanco, Nicolas Pätzmann, Pablo García-Triñanes
AAPS Pharmscitech
|
November 14, 2025
Exploring co-milling of poorly water-soluble drugs with swellable polymers to enhance the dissolution rate
Nicolas Pätzmann, Josef Beránek, Brendan T Griffin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 2, 2024
Predictive computational models for assessing the impact of co-milling on drug dissolution
Nicolas Pätzmann, Patrick J O'Dwyer, Josef Beránek, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 26, 2025
Co-milling of glass forming ability class III drugs: Comparing the impact of low and high glass transition temperatures
Nicolas Pätzmann, Josef Beránek, Brendan T Griffin, et al.
Page
of 1